*Programme subject to change
08:45 - Delegate Registration, Expo & Surgeries
Exhibition takes place in Foyer and Exeter 2, Surgeries in Drake Suite
09:30 - Conference Chair Introduction
Speaker: Doris-Ann Williams MBE, Chief Executive, BIVDA
09:40 - Keynote Address - UK AMR Diagnostics Collaborative
Speaker: Fiona Carragher, Deputy Chief Scientific Officer, NHS England
9.50 - How diagnostics can drive efficiency within the NHS
Speaker: Professor Adrian Newland CBE, Professor of Haematology, Barts and the London School of Medicine and Dentistry
10.05 – Using Pathology networks to drive efficient patient care
Speaker: David Wells, Head of Pathology Services Consolidation, NHS Improvements
10:20 - A partnered development of a circulating tumour ESR1 Mutation Test for the detection of metastatic breast cancer mutations indicative of resistance to endocrine hormone therapy
Speaker: Ciaran Fulton, Head of Diagnostics, Centre for Diagnostics Development (CDD), LifeArc
10:35 - Smartphone-enabled point of care testing - transforming the way we approach diagnosis and treatment
Speaker: Dr Neil Polwart, Novarum Founder, BBI Group Head of Mobile
As mobile technology has an ever increasing impact on our lives the permeation of mobile technology into diagnosis and treatment of disease is almost inevitable.Whilst there are many ways to envisage point of care tests integrating with mobile phones, we will describe our patent protected approach to detecting, analysing and interpreting low cost simple to use diagnostic devices for use outside traditional clinical laboratories.
In addition to describing case studies for projects covering a range of applications including infectious disease and monitoring chronic conditions, we will outline a vision for how smartphone connected point of care testing can be used to introduce improved antimicrobial stewardship.
10:50 - Panel Debate- How do we create a diagnostic pathway for the UK
Chair: Daniel Berman, Longitude Prize, Challenge Prize Centre, Nesta
Panelist: Doris-Ann Williams, Chief Executive, BIVDA
Panelist: Fiona Carragher, Deputy Chief Scientific Officer, NHS England
Panelist: Professor Adrian Newland CBE, Professor of Haematology, Barts and the London School of Medicine and Dentistry
Panelist: David Wells, Head of Pathology Services Consolidation, NHS Improvements
11:20 - Refreshments, Expo & Surgeries
11:40 - Diagnostics in action- Workshop Breakout session 1-Delegates choose 1 stream from each workshop session
Essex Suite- Stream 1 - Improvement in the quality and reproducibility of diagnostic assays
This presentation will address the application of reference materials measuring quality linked to a primary physical reference “the International Standard”, wherever possible, can provide assurance of the quality of the data and, in turn, support improved clinical management of patients.
Speaker: Clare Morris, Senior Scientist, NIBSC
Grenville Suite-Stream 2 - Improving clinician confidence and decision making in the management of patients over 65 presenting with acute frailty syndromes
This presentation will address a project which with the addition of a diagnostic tool facilitated improved decision making, earlier identification of illness and better patient management.
Speaker: Melinda McPherson, Trainee Advanced Clinical Practitioner, South central Ambulance Service
Exeter 1-Stream 3 - Case Study & Sponsor Required- Apply via abstract section
12.10- Diagnostics in action- Workshop Breakout session 2
Exeter 1-Stream 4- BiomArker-guided Duration of Antibiotic treatment in hospitalised PaTients with suspected Sepsis: the ADAPT-Sepsis Trial
This presentation will explore a recent UK-wide multi-centre randomised controlled trial to determine whether a treatment protocol based on monitoring CRP or PCT safely allow a reduction in duration of antibiotic therapy in hospitalised adult patients with suspected sepsis
Speaker: Professor Paul Dark, Chair of Critical Care Medicine, Manchester University NHS Foundation Trust and Northern NHS Care Alliance
Essex suite-Stream 5 - Creating a pathway for POC Diagnostics
Speaker: Lisa Harrison,Marketing Director
Region North Europe,Abbott
Grenville Suite-Stream 6 - Case Study & Sponsor Required- Apply via abstract section
12:45 - Lunch, Expo,Poster Session & Surgeries
Overcoming the challenges and progressing the Diagnostics landscape
13:45 - In-Vitro diagnostic regulations, challenges and opportunities in a post-Brexit UK
Speaker: Alison Dennis, Partner, Fieldfisher
14:05 - CASE STUDY in diagnostic test research: the i-sense EPSRC IRC in Early Warning Sensing Systems for Infectious Diseases
Speaker: Rachel McKendry, Professor, Biomedical Nanotechnology, London Centre for Nanotechnology, UK
14:20 -CASE STUDY: Real-world evaluation and implementation of a diagnostic test for pre-eclampsia
Speakers: Julie Hart & Guy Checketts
Pre-eclampsia (PE) is a multisystem hypertensive disorder that affects 3-5% of all pregnancies. The disease is a serious cause of maternal and foetal morbidity in the UK and clinical teams therefore have a high degree of suspicion for the disease and a low threshold for admitting pregnant women with suspected PE
Oxford AHSN has been leading a project with Roche Diagnostics and clinicians in the Oxford AHSN region to evaluate and implement the Elecsys® test as part of a new clinical pathway to reduce patient risk in maternity units.
This case study highlights the challenges and benefits of introducing a new clinical pathway and the importance of conducting a robust real world evaluation to facilitate implementation.
14:40 -CASE STUDY: CRP in Community Pharmacies
A recent study conducted in UK and estimated an 80% reduction in antibiotic Rx and also significantly reduced the attendance at GPs surgery.
These two factors make community pharmacy a cost effective site for POC CRP testing. As a result, the intervention has been included in NHS England grant to extend the service to more pharmacies already engaged in providing access to medication for the treatment of ear, nose, throat (ENT) conditions and for bacterial conjunctivitis which is due to start this coming flu season.
In addition it is planned to educate all members of the community-GP surgeries, schools, community groups etc in the town where the first trial was conducted to create a fully integrated POC CRP testing service in which all of the community are engaged.
Speaker: Mike Wakeman, Pharmacist & Healthcare Consultant
15:00 -CASE STUDY: Making the business case for Diagnostics within your organisation
Oldham has issues with higher levels of antibiotic prescribing than most other Greater Manchester CCGs. Oldham has the 2nd highest weighted prescribing of antibacterial. QIPP indicator (Quality, Innovation, Productivity and Prevention) showed 22 Oldham practices in the bottom national quartile.
Oldham Antimicrobial policy developed in 2013 in collaboration with North East sector to provide guidance to GPs about appropriate antibiotic prescribing on commonly presented infections. This failed to reduce the prescribing. In this presentation Anita Sharma will discuss how she gained funding support to tackle these high levels and her findings.
Speaker: Dr Anita Sharma,GPwSI Gynaecology, Clinical Lead Oldham GP Federation
15:20 - Closing Keynote- How Diagnostics make economic sense for the NHS
Lord O'Neill will present on the economic benefits brought to the UK Economy by utilising Diagnostics within our health service. Jim will address how Diagnostics is the single most important intervention in tackling Antimicrobial Resistance
Speaker: Lord Jim O'Neill of Gatley
15:40 - Chair closing remarks
15:50 - Conference Close